MAJOR REDUCTION OF ROTAVIRUS BUT NOT NOROVIRUS GASTROENTERITIS FOLLOWING UNIVERSAL IMMUNIZATION WITH ROTATEQ VACCINE IN FINLAND
ESPID Education, Maria Hemming, 31499
GENE EXPRESSION PROFILE AND CORRELATION WITH SEVERITY OF ILLNESS AMONG CHILDREN WITH ACUTE HEMATOGENOUS OSTEOMYELITIS CAUSED BY METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS
ESPID Education, Lawson Copley, 31494
THE FIRST NOROVIRUS BIVALENT GI.1/GII.4 VIRUS-LIKE PARTICLE (VLP) VACCINE IN MAN
ESPID Education, John Treanor, 31498
CLINICAL SIGNIFICANCE OF CO-INFECTIONS WITH VIRUSES AND BACTERIA
ESPID Education, Oana Falup-Pecurariu, 31190
Short and long-term complications of respiratory infections
ESPID Education, Vana Spoulou, 31191
Genome-wide studies in pediatric infectious diseases
ESPID Education, Mike Levin, 31193
Rheumatic disease in 2013
ESPID Education, Alberto Martini, 31194
LYME DISEASE
ESPID Education, Werner Zenz, 31195
Emerging respiratory viruses
ESPID Education, Albert Osterhaus, 31187
Viral infections, infectious wheezing and asthma development
ESPID Education, Sejal Saglani, 31188
Should influenza be prevented and treated?
ESPID Education, Terho Heikkinen, 31189
How vaccines prevent infections
ESPID Education, Adam Finn, 31185
AN UPDATE ON VACCINES TO PREVENT RESPIRATORY ILLNESSES IN CHILDREN
ESPID Education, Edwards Kathryn, 31186
COULD WE HAVE A UNIFIED EUROPEAN VACCINATION SCHEDULE? - RATIONALE
ESPID Education, Jacek Mrukowicz, 20842
COULD WE HAVE A UNIFIED EUROPEAN VACCINATION SCHEDULE?
ESPID Education, Pier Luigi Lopalco, 20843
CURRENT DIAGNOSIS AND TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN CHILDREN IN THE ERA OF PNEUMOCOCCAL VACCINATION: OLD VERSUS NEW WORLD - EUROPE
ESPID Education, Javier Diez-Domingo, 20844
CURRENT DIAGNOSIS AND TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN CHILDREN IN THE ERA OF PNEUMOCOCCAL VACCINATION: OLD VERSUS NEW WORLD - USA
ESPID Education, Samir S Shah, 20845
BLUE VERSUS RED - RECOMMENDATIONS ACROSS THE OCEAN
ESPID Education, Mike Sharland, 20846
INFANT IMMUNIZATION: STARTING FROM PREGNANCY
ESPID Education, Ener Dinleyici, 20839
ADDRESSING CONCERNS ABOUT VACCINES
ESPID Education, Gary S. Marshall, 20840
HOW PAEDIATRIC INFECTIOUS DISEASE SPECIALISTS MAY ASSIST INTERNISTS TO DEVELOP A LIFETIME VACCINATION SCHEDULE
ESPID Education, Ulrich Heininger, 20841
IMPROVING THE EVIDENCE BASE FOR ANTIBIOTIC USE IN EUROPE - WHAT DO WE DO AND WHY DO WE DO IT
ESPID Education, Nikos Spyridis, 20835
PROPOSED WAYS OF MEASUREMENT OF ANTIBIOTIC CONSUMPTION IN PAEDIATRIC HOSPITALS
ESPID Education, Herman Goossens, 20836
ECDC-PPS OF HEALTHCARE-ASSOCIATED INFECTIONS AND ANTIMICROBIAL USE IN ACUTE CARE HOSPITALS: EXAMPLES OF PAEDIATRIC AND NEONATAL RESULTS
ESPID Education, Carl Suetens, 20837
ANTIMICROBIAL STEWARDSHIP IN PAEDIATRIC HOSPITALS
ESPID Education, Theoklis Zaoutis, 20838
EPIDEMIOLOGY OF RESISTANT GRAM-POSITIVE BACTERIA
ESPID Education, Maria Koliou, 20831
EPIDEMIOLOGY OF RESISTANT AND PAN-RESISTANT GRAM-NEGATIVE BACTERIA
ESPID Education, George L. Daikos, 20832
MANAGEMENT OF INFECTIONS CAUSED BY RESISTANT (RB) AND PAN-RESISTANT BACTERIA (PRB) IN CHILDREN
ESPID Education, Robert Cohen, 20833
PREVENTION OF HORIZONTAL TRANSMISSION OF MICROBES: INFECTION CONTROL ISSUES IN THE HOSPITAL
ESPID Education, Walter Zingg, 20834
PROSPECTS FOR NOVEL TUBERCULOSIS VACCINES: WHERE DO WE STAND?
ESPID Education, Søren Tetens Hoff, 20828
PREVENTION AND TREATMENT OF TUBERCULOSIS IN IMMUNOCOMPROMISED CHILDREN
ESPID Education, Beate Kampmann, 20829
EPIDEMIOLOGY AND MANAGEMENT OF MULTIDRUG-RESISTANT AND EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS IN CHILDREN
ESPID Education, H. Simon Schaaf, 20830
NEWER ANTIBACTERIAL AGENTS FOR GRAM-POSITIVE INFECTIONS
ESPID Education, George Syrogiannopoulos, 20825
ANTIBACTERIAL AGENTS FOR RESISTANT GRAM NEGATIVE INFECTIONS (COLISTIN, TIGECYCLINE, FOSFOMYCIN)
ESPID Education, Charalampos Antachopoulos, 20826
NEW ANTIFUNGAL IN PEDIATRICS
ESPID Education, Adilia Warris, 20827
MICROBIOLOGY OF CYSTIC FIBROSIS
ESPID Education, Niels Hoeiby, 20821
FUNGAL PULMONARY SYNDROMES IN CYSTIC FIBROSIS
ESPID Education, Kris De Boeck, 20822
INHALED VERSUS INTRAVENOUS ANTIBIOTICS: PHARMACOKINETICS/PHARMACODYNAMICS ISSUES
ESPID Education, Roger Brüggemann, 20823
GBS AND THE NEONATE: PREVENTION STRATEGIES
ESPID Education, Pierrette Melin, 20815
LATE-ONSET INFECTIONS IN NICU
ESPID Education, Paul Heath, 20816
PREVENTION OF CANDIDA INFECTIONS IN NEONATES: DIFFERENT VIEWPOINTS - NEONATOLOGY
ESPID Education, Paolo Manzoni, 20817
PREVENTION OF CANDIDA INFECTIONS IN NEONATES: DIFFERENT VIEWPOINTS - MYCOLOGY
ESPID Education, J Peter Donnelly, 20818
LONG-TERM OUTCOMES OF CONGENITAL CYTOMEGALOVIRUS (CMV) INFECTION IN SWEDEN AND THE UNITED KINGDOM
ESPID Education, Claire Townsend, 20819
SCREENING FOR NOSOCOMIAL VIRAL INFECTIONS IN A NEONATAL INTENSIVE CARE UNIT
ESPID Education, Andre Kidszun, 20820
STRENGTHENING EUROPE´S DEFENCES AGAINST INFECTIOUS DISEASES OF THE YOUNG
ESPID Education, Giesecke Johan, 20812
PROTEOMICS AND GENOMICS - CAN THEY HELP US UNDERSTAND THE PATHOGENESIS OF INFECTIOUS DISEASES?
ESPID Education, Mike Levin, 20813
TRANSLATIONAL APPROACHES AND IMPLEMENTATION OF GUIDELINES IN PAEDIATRIC INFECTIOUS DISEASES
ESPID Education, Thomas Walsh, 20814
TUBERCULOSIS: FROM BENCH TO BEDSIDE
ESPID Education, Ben Marais, 8009
PNEUMOCOCCAL VACCINATION STRATEGIES: THE PUBLIC HEALTH PERSPECTIVE
ESPID Education, Kate O'Brien, 8008
Novel insights into the distribution of soil-transmitted helminthiasis and schistosomiasis using real-time PCR diagnosis
ESPID Education, Lisette Van Lieshout, 8007
IL-15 GENE POLYMORPHISMS ARE ASSOCIATED WITH RESISTANCE TO VISCERAL LEISHMANIASIS
ESPID Education, Manoochehr Rasouli, 8006
A NOVEL, FULLY AUTOMATED SAMPLE-TO-RESULT REAL-TIME PCR ASSAY FOR POINT-OF-CARE DETECTION OF DENGUE VIREMIA
ESPID Education, Steven Hatch, 8005
MALARIA AND SALMONELLA CO-INFECTION: A CONFLICT BETWEEN PATHOGEN TOLERANCE AND RESISTANCE
ESPID Education, Aubrey Cunnington, 8004
VISCERAL LEISHMANIASIS
ESPID Education, Shyam Sundar, 8003
CONTROL OF NEGLECTED TROPICAL DISEASES
ESPID Education, David Molyneux, 8002
IMPACT OF THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE ON INVASIVE PNEUMOCOCCAL DISEASE IN ALASKA NATIVE CHILDREN: RESULTS OF A CLINCAL TRIAL
ESPID Education, Rosalyln Singleton, 8086
THE EPIDEMIOLOGY OF INVASIVE MENINGOCOCCAL DISEASE IN EUROPE, 2008 AND 2009
ESPID Education, Ida Czumbel, 8087
PERTUSSIS RISK IN CHILDREN AS A FUNCTION OF TIME SINCE RECEIPT OF THE 5TH DOSE OF ACELLULAR PERTUSSIS VACCINE
ESPID Education, Nicola Klein, 8088
DEFINITION OF A CORRELATE OF PROTECTION FOR INACTIVATED INFLUENZA VACCINES IN CHILDREN LESS THAN FIVE YEARS OF AGE
ESPID Education, Steven Black, 8089
DETECTION OF MYCOPLASMA PNEUMONIAE IN HEALTHY CHILDREN BY REAL TIME PCR-PRELIMINARY DATA FROM THE MYMIC STUDY
ESPID Education, Emiel Spuesens, 8090
DETERMINING THE QUALITY OF CARE FOR ACUTE RESPIRATORY INFECTIONS IN MALAWIAN CHILDREN
ESPID Education, Erica Chapin, 8091
PAEDIATRIC ANTIBIOTIC USE IN THE NETHERLANDS BETWEEN 1996 AND 2010: AN ARPEC STUDY
ESPID Education, Sandra de Bie, 8093
MEASLES AND RUBELLA OUTBREAKS
ESPID Education, Rebecca Martin, 8001
SALMONELLA INFECTIONS IN DEVELOPING COUNTRIES
ESPID Education, Zulfiqar Bhutta, 8000
ANTIVIRAL THERAPY
ESPID Education, Hans L. Zaaijer, 7993
PHARMACOGENOMICS AND ANTIMICROBIAL AGENTS
ESPID Education, Andrew Owen, 7992
CONTINUING INCREASE IN 19A AND 6C SEROTYPE CARRIAGE IN CHILDREN AFTER THE INTRODUCTION OF PCV-7 IN THE NETHERLANDS
ESPID Education, S.M.P.J. Prevaes, 7709
SAFETY OF ADJUVANTED PANDEMIC INFLUENZA VACCINES: BACKGROUND RATE OF NARCOLEPSY IN EUROPE
ESPID Education, Jan Bonhoeffer, 7750
MOLECULAR DIAGNOSIS OF VIRAL INFECTIONS
ESPID Education, Martin Schutten, 7990
NEW DIAGNOSTIC METHODS FOR TUBERCULOSIS
ESPID Education, Nigel Curtis, 7989
MOLECULAR DIAGNOSIS OF INFECTIOUS DISEASES: QUO VADIS?
ESPID Education, Alex Van Belkum, 7988
HOW ACADEMIA AND INDUSTRY CAN CONTRIBUTE TO THE PROMISE OF CURRENT AND NEW VACCINES
ESPID Education, Sian Clayden, 7999
CLEAR AND ALIGNED COMMUNICATION IS VITAL TO REACH THE DESIRED OUTCOMES
ESPID Education, Joanne Yarwood, 7998
WHAT CAN WE LEARN FROM STRATEGIES THAT DO & DON'T WORK?
ESPID Education, Hanna Nohynek, 7997
IMMUNISATION PROGRAMMES: THE GLOBAL PERSPECTIVE
ESPID Education, Pierre Van Damme, 7995
VACCINATION POLICIES: THE EUROPEAN EXPERIENCE
ESPID Education, Kari Johansen, 7994
HIV/AIDS IN CHILDREN
ESPID Education, Diana Gibb, 7987
FROM IMMUNODEFICIENCIES TO INFECTIOUS DISEASES
ESPID Education, Alain Fischer, 7986
INHIBITING THE HOST FOR KILLING INTRACELLULAR PATHOGENS
ESPID Education, Jacques Neefjes, 7985
THE PARADOX OF GLOBAL HEALTH: SUCCESS, YET CRISIS
ESPID Education, Richard Horton, 7984
CAN WE LEARN FROM MOTHER TO CHILD TRANSMISSION OF HIV-1 FOR THE MILLENIUM DEVELOPMENT GOAL 4 AND BEYOND?
ESPID Education, Francoise Barre-Sinoussi, 7982
“ EFFECT OF HOME BASED CHILD CARE ON DIARREAL DEAHTS IN A TRIBAL POPULATION: RESULT OF A FIELD TRIAL.”
ESPID Education, Abhijit Bharadwaj, 7661
ENTEROVIRUS AND HUMAN PARECHOVIRUS INFECTIONS ARE A MAJOR CAUSE OF FEVER OF UNKNOWN ORIGIN IN YOUNG CHILDREN
ESPID Education, Eveline P De Jong, 7664
DURATION OF SHEDDING OF HUMAN PARECHOVIRUS IN FAECES OF YOUNG CHILDREN AFTER SYMPTOMATIC INFECTION.
ESPID Education, Joanne G. Wildenbeest, 7666
COMPARISON OF VIRULENCE TRAITS BETWEEN ESCHERICHIA COLI CLINICAL ISOLATES CAUSING EARLY NEONATAL SEPSIS AND THOSE COLLECTED FROM HEALTHY NEONATES.
ESPID Education, Elisabet Guiral, 7689
AETIOLOGY AND RISK FACTORS FOR HOSPITAL-ACQUIRED BACTERAEMIA IN CHILDREN ADMITTED TO A LONDON TERTIARY REFERRAL HOSPITAL
ESPID Education, A Perez-Lopez, 7690
ANTIMICROBIAL RESISTANCE OF ESCHERICHIA COLI CLINICAL ISOLATES CAUSING NEONATAL SEPSIS.
ESPID Education, Sara Soto, 7691
RAPID REDUCTION IN INVASIVE PNEUMOCOCCAL DISEASE (IPD) AFTER INTRODUCTION OF PCV7 TO THE NATIONAL IMMUNIZATION PLAN (NIP) IN ISRAEL
ESPID Education, Noga Givon-Lavi, 7711
IMPACT OF PNEUMOCOCCAL VACCINATION IN DENMARK DURING THE FIRST 3 YEARS AFTER PCV7 INTRODUCTION IN THE CHILDHOOD IMMUNIZATION PROGRAMME
ESPID Education, Helene Ingels, 7712
RISK FACTORS FOR PREVALENT TUBERCULOSIS INFECTION AMONG CHILDREN IN GREENLAND
ESPID Education, Bolette Soborg, 7713
RETROSPECTIVE COMPARISON OF PANDEMIC INFLUENZA A/H1N1 (2009/2010) CLINICAL CHARACTERISTICS VERSUS SEASONAL INFLUENZA A (2007-2009) IN HOSPITALIZED CHILDREN IN BASEL, SWITZERLAND
ESPID Education, Ulrich Heininger, 7732
INCREASED INCIDENCE OF PERTUSSIS IN A TERTIARY CARE HOSPITAL IN MADRID (SPAIN) 2010. EPIDEMIOLOGICAL AND CLINICAL FEATURES OF THIS DISEASE
ESPID Education, Ana Malo de Molina Meléndez, 7734
A PRACTICAL APPROACH TO Q FEVER IN CHILDREN
ESPID Education, Ingeborg Bart, 7735
IMMUNOGENICITY AND SAFETY OF INTRADERMAL INFLUENZA VACCINES WITH DIFFERENT AMOUNT OF ANTIGENS IN OTHERWISE HEALTHY CHILDREN
ESPID Education, Susanna Esposito, 7751
SAFETY OF A THREE SUBUNIT INFLUENZA VACCINE IN HEALTH CARE WORKERS IN KURDISTAN: A CROSS SECTIONAL STUDY
ESPID Education, Jafar Soltani, 7752
VACCINE UPTAKE DETERMINANTS IN THE NETHERLANDS
ESPID Education, Hester de Melker, 7779
EPIDEMIOLOGY OF THE UNVACCINATED: A BEHAVIOUR CHANGE COMMUNICATIONS FRAMEWORK AND TOOLKIT FOR THE WHO EUROPEAN REGION.
ESPID Education, Robb Butler, 7780
GENOTYPE DISTRIBUTION AND ROTAVIRUS GASTROENTERITIS HOSPITALIZATIONS FOUR YEARS AFTER VACCINATION IN SAO PAULO, BRAZIL
ESPID Education, Marco Safadi, 7784
IMMUNOGLOBULIN DEFICIENCY IN CHILDREN WITH HIB VACCINE FAILURE
ESPID Education, Clarissa Oeser, 7955
DETECTION OF FUSOBACTERIAL INFECTION IN A CULTURE-NEGATIVE BRAIN ABSCESS WITH 16S rRNA GENE PCR
ESPID Education, Christina Kortsalioudaki, 7957

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.


Save Settings